Public Health

The CDC reported more than 200,000 cases of syphilis in 2022, a 17% increase compared with the previous year. In response, the CDC provided new recommendations for testing syphilis in the laboratory.

The once-monthly RNA interference injection medication received FDA approval based on results from the phase II PHYOX2 clinical trial and phase III PHYOX3 extension study.

Using data from the Centers for Medicare & Medicaid Services Chronic Conditions Warehouse database, researchers set out to estimate the risk of gout following recombinant zoster vaccination among adults...

Researchers evaluated the prevalence of depression disorders in pediatric patients to determine if there is a mental health impact on this age group.

Using data collected in the American College of Surgeons National Surgical Quality Improvement Program database, researchers assessed how endometriosis affects post-operative outcomes in patients undergoing...

Osteoarthritis is a common chronic and degenerative disease among adults. A group of experts estimated the disease’s burden spanning two decades and the projection of burden to 2050.

In effort to understand the effect of the COVID-19 pandemic among patients with sickle cell disease, researchers compared outcomes and characteristics of hospitalized patients both before and during the...

In a prospective study, researchers evaluated the immune response and adverse events of COVID-19 and seasonal influenza vaccine coadministration.

The FDA approved ustekinumab-auub as an interchangeable biosimilar with ustekinumab for multiple inflammatory diseases.

Tirzepatide is now approved for a new indication. The dual GIP/GLP-1 agonist was previously approved for treating type 2 diabetes in May 2022.